购物车
全部删除
您的购物车当前为空
Glypican 3/GPC3 Protein, Human, Recombinant (His) V2 is expressed in HEK293 Cells. The accession number is P51654-1.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 μg | ¥ 329 | 6-8日内发货 | |
| 10 μg | ¥ 527 | 6-8日内发货 | |
| 20 μg | ¥ 859 | 5日内发货 | |
| 50 μg | ¥ 1,680 | 5日内发货 | |
| 100 μg | ¥ 2,830 | 5日内发货 | |
| 200 μg | ¥ 5,010 | 5日内发货 | |
| 500 μg | ¥ 10,600 | 5日内发货 |
| 生物活性 | Immobilized Human GPC3, His Tag at 0.5 μg/ml (100 μl/Well). Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 4.7 ng/ml determined by ELISA. |
| 产品描述 | Glypican 3/GPC3 Protein, Human, Recombinant (His) V2 is expressed in HEK293 Cells. The accession number is P51654-1. |
| 种属 | Human |
| 表达系统 | HEK293 Cells |
| 标签 | C-His |
| 蛋白编号 | P51654-1 |
| 别名 | SGBS1,SGBS,SGB,SDYS,OCI-5,MXR7,GTR2-2,Glypican 3,DGSX |
| 蛋白构建 | Gln25-His559 |
| 蛋白纯度 | > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| 分子量 | 61.6 kDa (Predicted); 42 kDa, 70-115 kDa (Due to glycosylation) |
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
| 蛋白性状 | Lyophilized powder |
| 缓冲液 | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| 复溶方法 | Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/mL. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| 存储 | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| 运输方式 | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
| 研究背景 | Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed. |